Inclusion criteria | |
 • Age ≥ 18 and < 75 years | |
 • VAS ≥ 70/100 or NRS ≥ 7/10 | |
 • Patient affiliated with or beneficiary of a social security category | |
 • For women (childbearing age) | |
  ○ Effective contraception (oral contraception, intrauterine device or use of condoms) | |
  ○ Menopausal status (amenorrhea less than 12 months before the inclusion visit) | |
  ○ Objectivized sterility (diagnosis or surgically) | |
Exclusion criteria | |
 • Chronic pain (> 3 months) | |
 • Taking opioids more than 10 days (including opioids as tramadol and/or codeine) | |
 • Taking opioids in the emergency room within 4 h | |
 • Taking rifampicin | |
 • Impaired ability to discern, cognitive impairment | |
 • Morphine-related contraindications | |
  ○ Chronic obstructive or restrictive respiratory failure known or suspected, compensated or not | |
  ○ Hypersensitivity to the active substance or to any of the excipients | |
  ○ Severe hepatocellular insufficiency (known or suspected) | |
  ○ Chronic renal failure known or suspected | |
  ○ Acute renal failure (creatinine clearance < 60 ml/min/1.73 m2 and/or increase of 25% from baseline) | |
  ○ Uncontrolled epilepsy | |
  ○ Cranial trauma (intracranial hypertension) | |
  ○ Associations with buprenorphine, nalbuphine, pentazocine, or naltrexone | |
 • Active drug history or practice(s) | |
 • Obvious need to reduce fracture or dislocation in the emergency room | |
 • Suspected occlusive syndrome | |
 • SpO2 < 95% | |
 • Respiratory rate (RR) < 12 breaths/min | |
 • Glasgow Coma Scale (GCS) < 15 or other alertness disorders | |
 • Heart rate (HR) < 50 bpm and/or auriculo-ventricular block (PR interval > 200 ms) | |
 • Arterial hypotension with systolic blood pressure TA syst < 100 mmHg | |
 • Pregnancy or lactation | |
 • Persons deprived of their liberty by an administrative or judicial decision, persons placed under the safeguard of justice, guardianship | |
 • Patients with poor comprehension of spoken or written French | |
 • Patients participating in another interventional clinical study | |
 • Contraindication related to the use of saline solution | |
 • Contraindications related to the use of aerosol: | |
  ○ Necessity to access the face | |
  ○ Allergy known to plastic | |
  ○ Claustrophobia |